Zykov M P, Rudenko L G, Zoshchenkova N Y, Rafael'skaya T I
J Hyg Epidemiol Microbiol Immunol. 1980;24(2):212-8.
Subunit adsorbed chemical influenza vaccine [ACI] was tested in subcutaneous administration by the needleless and syringe methods. A weak reactogenicity and a high immunogenic activity of the ACI vaccine was demonstrated after a single administration by the needleless and syringe methods [73.0---75.0% of seroconversions with a geometric mean of the titre of 1:91.0---1:169.0 and a relative increase in antibody titre of 8.1---14.9]. Revaccination increased the mentioned indices to 75.0---86.0%, 1:128.0---1:181.0 and 11.3---16.0, respectively. A many-sided comparison of three preparations [ACI vaccine, "Vaxgrip" and "Mutagripe"] permitted to reveal a number of advantages in the Soviet vaccine. However, all the three preparations ensured an expressed protection against influenza virus.
对亚单位吸附化学流感疫苗[ACI]进行了皮下注射测试,采用无针注射法和注射器注射法。通过无针注射法和注射器注射法单次给药后,ACI疫苗显示出较弱的反应原性和较高的免疫原活性[血清转化率为73.0%-75.0%,几何平均滴度为1:91.0-1:169.0,抗体滴度相对增加8.1%-14.9%]。再次接种分别将上述指标提高到75.0%-86.0%、1:128.0-1:181.0和11.3%-16.0。对三种制剂[ACI疫苗、“Vaxgrip”和“Mutagripe”]进行多方面比较后,发现苏联疫苗有许多优点。然而,所有这三种制剂都能提供对流感病毒的明显保护。